Volume 1, Issue 4


Kelly Perdew, winner of the second season of NBC’s The Apprentice, Has Been Announced as the Keynote Speaker at ESE 2007

Perdew was also president of www.eteamz.com and CoreObjects Software and co-founder, president and CEO of an event marketing and production company called K12 Productions. He earned a bachelor’s degree from the United States Military Academy, West Point, an MBA from The Anderson School at UCLA and a JD from the UCLA School of Law.

For more information about Early Stage East 2007, visit the web at www.earlystageeast.org/ese_conf/conference_home.asp




Company to Watch: Morphotek, Inc.

Morphotek was recently acquired by Eisai Corporation of North America, a wholly-owned subsidiary of Tokyo-based Eisai Co., Ltd., to operate as an independent subsidiary in developing therapeutic antibodies for cancer, inflammation and infectious diseases.

Over its six year history, Morphotek has successfully raised $78 million in venture capital, most recently closing a $40 million Series D financing in October of 2006. In April 2007, the company was acquired by Eisai for $325 million plus net excess cash on the company balance sheet. It’s CEO, Dr. Nicolas Nicolaides, has recently been named one of the Top 20 Scientists in R&D by R&D Directions, a bi-monthly magazine that provides readers with extensive knowledge of compounds progressing through the pharmaceutical pipeline as well as the companies developing these compounds. Morphotek has also been named on of the Top Three Fastest Growing Companies in the Philadelphia region by the Philadelphia 100®, a yearly event hosted by the Entrepreneurs Forum of Greater Philadelphia, the Philadelphia Business Journal and the Wharton SBDC which honors the fastest growing, privately-held companies in the Greater Philadelphia Region.

For more information about Morphotek, visit their website at www.morphotek.com



Volume 1, Issue 4
May 11, 2007




























“ESE is a wonderful platform for young companies to get exposure to a wide range of investors and potential business leads.”

Nicholas C. Nicolaides, Ph.D.
President & CEO
Morphotek, Inc.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
To remove your name from our mailing list, please click here.
Questions or comments? E-mail us at [email protected] or call (302) 777-2460.